Abstract
Huntington's disease (HD) is an inherited, rare neurodegenerative disorder caused by repeated mutations in the huntingtin gene. In Brazil, there are estimated to be 13,000 to 19,000 carriers. A literature review highlighted specific challenges in Brazil, including the absence of curative treatments, the demand for a specialized and sensitive approach for HD patients in the Unified Health System (SUS), and the scarcity of epidemiological studies. The 2014 National Policy for Comprehensive Care of People with Rare Diseases (PNAIDR) endeavors to provide access to diagnosis, treatment, rehabilitation, and palliative care for individuals with HD. However, meeting these patients' specific needs poses significant challenges. Effective implementation of strategies to improve early diagnosis, patient support, and quality of life necessitates close collaboration between health professionals, researchers, and policymakers.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Revista Ibero-Americana de Humanidades, Ciências e Educação
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
